BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 7986687)

  • 1. Cutaneous pseudolymphomas: classification and differential diagnosis.
    Rijlaarsdam JU; Willemze R
    Semin Dermatol; 1994 Sep; 13(3):187-96. PubMed ID: 7986687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnosis and classification of cutaneous pseudolymphoma. Historical review and perspectives].
    Rijlaarsdam JU; Willemze R
    Ann Dermatol Venereol; 1993; 120(1):100-6. PubMed ID: 8338321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary cutaneous lymphoproliferative disorders with dual lineage rearrangement.
    Kazakov DV; Kutzner H; Palmedo G; Boudova L; Michaelis S; Michal M; Vanecek T; Magro CM; Mukensnabl P; Dummer R; Burg G; Kempf W
    Am J Dermatopathol; 2006 Oct; 28(5):399-409. PubMed ID: 17012914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudolymphoma and cutaneous lymphoma: facts and controversies.
    Bergman R
    Clin Dermatol; 2010; 28(5):568-74. PubMed ID: 20797521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Approach to lymphoproliferative infiltrates of the skin. The difficult lesions.
    Kempf W; Dummer R; Burg G
    Am J Clin Pathol; 1999 Jan; 111(1 Suppl 1):S84-93. PubMed ID: 9894473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects.
    Burg G; Kempf W; Cozzio A; Feit J; Willemze R; S Jaffe E; Dummer R; Berti E; Cerroni L; Chimenti S; Diaz-Perez JL; Grange F; Harris NL; Kazakov DV; Kerl H; Kurrer M; Knobler R; Meijer CJ; Pimpinelli N; Ralfkiaer E; Russell-Jones R; Sander C; Santucci M; Sterry W; Swerdlow SH; Vermeer MH; Wechsler J; Whittaker S
    J Cutan Pathol; 2005 Nov; 32(10):647-74. PubMed ID: 16293178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New aspects in the classification of cutaneous lymphomas].
    Erós N; Károlyi Z; Kovács A
    Orv Hetil; 2001 Feb; 142(8):393-8. PubMed ID: 11263077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Classification of cutaneous lymphomas.
    Burg G; Dummer R; Kerl H
    Dermatol Clin; 1994 Apr; 12(2):213-7. PubMed ID: 8045033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathology of cutaneous T-cell lymphoma.
    Burg G; Dummer R; Dommann S; Nestle F; Nickoloff B
    Hematol Oncol Clin North Am; 1995 Oct; 9(5):961-95. PubMed ID: 8522491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The new World Health Organization-European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas: a practical marriage of two giants.
    Slater DN
    Br J Dermatol; 2005 Nov; 153(5):874-80. PubMed ID: 16225594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous T-cell lymphomas (including rare subtypes). Current concepts. II.
    Paulli M; Berti E
    Haematologica; 2004 Nov; 89(11):1372-88. PubMed ID: 15531460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous T-cell and NK-cell lymphomas: the WHO-EORTC classification and the increasing recognition of specialized tumor types.
    Kinney MC; Jones D
    Am J Clin Pathol; 2007 May; 127(5):670-86. PubMed ID: 17439828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The spectrum of cutaneous lymphomas in patients less than 20 years of age.
    Fink-Puches R; Chott A; Ardigó M; Simonitsch I; Ferrara G; Kerl H; Cerroni L
    Pediatr Dermatol; 2004; 21(5):525-33. PubMed ID: 15461755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinico-pathological spectrum of primary cutaneous lymphoma other than mycosis fungoides/Sezary syndrome.
    Oschlies I; King RL; Dotlic S; Montes-Moreno S; Ponzoni M; Traverse-Glehen A; Calaminici M; Ferry JA; Ott G; Goodlad JR
    Virchows Arch; 2020 May; 476(5):683-699. PubMed ID: 31781845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic/natural killer cell cutaneous lymphomas. Report of EORTC Cutaneous Lymphoma Task Force Workshop.
    Santucci M; Pimpinelli N; Massi D; Kadin ME; Meijer CJ; Müller-Hermelink HK; Paulli M; Wechsler J; Willemze R; Audring H; Bernengo MG; Cerroni L; Chimenti S; Chott A; Díaz-Pérez JL; Dippel E; Duncan LM; Feller AC; Geerts ML; Hallermann C; Kempf W; Russell-Jones R; Sander C; Berti E;
    Cancer; 2003 Feb; 97(3):610-27. PubMed ID: 12548603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognosis of primary cutaneous lymphomas].
    Grange F; Bagot M
    Ann Dermatol Venereol; 2002 Jan; 129(1 Pt 1):30-40. PubMed ID: 11937927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunophenotyping and gene rearrangement analysis provide additional criteria to differentiate between cutaneous T-cell lymphomas and pseudo-T-cell lymphomas.
    Bakels V; van Oostveen JW; van der Putte SC; Meijer CJ; Willemze R
    Am J Pathol; 1997 Jun; 150(6):1941-9. PubMed ID: 9176388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunohistochemical classification of cutaneous lymphomas and pseudolymphomas].
    Smolle J; Kaudewitz P; Aberer E; Torne R; Burg G; Kerl H
    Hautarzt; 1987 Aug; 38(8):461-6. PubMed ID: 3308776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary cutaneous lymphomas.
    Willemze R
    Curr Opin Oncol; 2000 Sep; 12(5):419-25. PubMed ID: 10975548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-transplant cutaneous T-cell lymphomas.
    Lok C; Viseux V; Denoeux JP; Bagot M
    Crit Rev Oncol Hematol; 2005 Oct; 56(1):137-45. PubMed ID: 16046144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.